`
`
`
`Filed: April 19, 2017
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`MYLAN PHARMACEUTICALS INC., ACTAVIS
`LABORATORIES FL, INC., AMNEAL PHARMACEUTICALS LLC,
`AMNEAL PHARMACEUTICALS OF NEW YORK, LLC, DR. REDDY'S
`LABORATORIES, INC., DR. REDDY'S LABORATORIES, LTD.,
`SUN PHARMACEUTICALS INDUSTRIES, LTD.,
`SUN PHARMACEUTICALS INDUSTRIES, INC.,
`TEVA PHARMACEUTICALS USA, INC., WEST-WARD
`PHARMACEUTICAL CORP., and HIKMA PHARMACEUTICALS, LLC,
`Petitioners
`
`v.
`
`JANSSEN ONCOLOGY, INC.,
`
`Patent Owner
`
`Case IPR2016-013321
`Patent 8,822,438 B2
`
`
`
`
`
`UPDATED MANDATORY NOTICES PURSUANT
`TO 37 C.F.R. §§ 42.8(a)(3), 42.8(b)(3) AND 42.8(b)(4)
`
`
`1 Case IPR2017-00853 has been joined with this proceeding.
`
`
`
`
`Pursuant to 37 C.F.R. §§ 42.8(a)(3), 42.8(b)(3) and 42.8(b)(4), Petitioner
`
`Mylan Pharmaceuticals Inc. (“Mylan”), hereby submits an updated identification
`
`of counsel and service information.
`
`A.
`
`Identification of Counsel (37 C.F.R. § 42.8(b)(3))
`
`Mylan updates its identification of counsel to include Shannon M.
`
`Bloodworth, Bryan D. Beel, Emily J. Greb, and Robert D. Swanson as additional
`
`back up counsel. Brandon M. White and Crystal R. Canterbury remain as lead and
`
`back up counsel, respectively.
`
`Lead Counsel
`Brandon M. White
`(Reg. No. 52,354)
`Perkins Coie LLP
`700 13th St., NW, Suite 600
`Washington, DC 20005
`BMWhite@perkinscoie.com
`Tel: (202) 654-6206
`Fax: (202) 654-9681
`Additional Back Up Counsel
`Shannon M. Bloodworth
`(admitted pro hac vice)
`Perkins Coie LLP
`700 13th St., NW, Suite 600
`Washington, DC 20005
`SBloodworth@perkinscoie.com
`Tel: (202) 654-6204
`Fax: (202) 654-9135
`
`Back Up Counsel
`Crystal R. Canterbury
`(Reg. N. 69,853)
`Perkins Coie LLP
`700 13th St., NW, Suite 600
`Washington, DC 20005
`CCanterbury@perkinscoie.com
`Tel: (202) 654-6383
`Fax: (202) 654-9962
`Additional Back Up Counsel
`Bryan D. Beel
`(admitted pro hac vice)
`Perkins Coie LLP
`1120 NW Couch St., 10th Floor
`Portland, OR 97209
`BBeel@perkinscoie.com
`Tel: (503) 727-2116
`Fax: (503) 346-2116
`
`- 1 -
`
`
`
`Additional Back Up Counsel
`Emily J. Greb
`(Reg. No. 68,244)
`Perkins Coie LLP
`1 East Main Street, Suite 201
`Madison, WI 53703
`EGreb@perkinscoie.com
`Tel: (608) 663-7494
`Fax: (608) 283-4494
`
`
`Additional Back Up Counsel
`Robert D. Swanson
`(admitted pro hac vice)
`Perkins Coie LLP
`700 13th St., NW, Suite 600
`Washington, DC 20005
`RSwanson@perkinscoie.com
`Tel: (202) 654-1729
`Fax: (202) 654-6211
`
`B.
`
`Service Information (37 C.F.R. § 42.8(b)(4))
`
`Please direct all correspondence to lead counsel and back-up counsel at the
`
`contact information above. Mylan consents to service by electronic mail at
`
`bmwhite@perkinscoie.com, ccanterbury@perkinscoie.com,
`
`sbloodworth@perkinscoie.com, bbeel@perkinscioe.com, egreb@perkinscoie.com,
`
`
`
`
`
`/Brandon M. White/
`Brandon M. White
`Reg. No. 52,354
`
`PERKINS COIE LLP
`700 13th Street, NW, Suite 600
`Washington, D.C. 20005
`Telephone: (202) 654-6204
`Facsimile: (202) 654-6211
`Email: bmwhite@perkinscoie.com
`
`Attorney for Mylan Pharmaceuticals Inc.
`
`- 2 -
`
`
`
`and rswanson@perkinscoie.com.
`
`Dated: April 19, 2017
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that the foregoing UPDATED
`
`
`
`MANDATORY NOTICES PURSUANT TO 37 C.F.R. §§ 42.8(a)(3), 42.8(b)(3)
`
`AND 42.8(b)(4) was served electronically via email as follows:
`
`Petitioners:
`
`Samuel S. Park
`Jovial Wong
`Ryan B. Hauer
`Winston & Strawn LLP
`spark@winston.com
`jwong@winston.com
`rhauer@winston.com
`
`
`
`Patent Owners:
`
`Dianne B. Elderkin
`Barbara L. Mullin
`Ruben H. Munoz
`Akin Gump Strauss Hauer & Feld LLP
`JANS-ZYTIGA@akingump.com
`
`Todd L. Krause
`David T. Pritikin
`Bindu Donovan
`Paul J. Zegger
`Sidley Austin LLP
`ZytigaIPRTeam@sidley.com
`
`
`
`Dated: April 19, 2017
`
`
`
`
`
`
`
`
`
`/Brandon M. White/
`Brandon M. White
`
`Attorney for Mylan Pharmaceuticals Inc.
`
`